Zhitong Finance App News, China Tongpo (01763.HK) issued an announcement. On December 31, 2025, according to the relevant authorities, the company's non-wholly-owned subsidiary, Shenzhen CNNC Headway Biotechnology Co., Ltd. (Headway), should recently make up corporate income tax, value-added tax and other taxes of RMB 188 million from January 1, 2021 to December 31, 2024, and a total of RMB 271 million in late fees, mainly involving sales expenses and abnormal inventory losses of RMB 271 million during the aforementioned year. As of the date of this announcement, Headway has paid this tax. The tax-related matter is expected to affect the annual profit due to equity shareholders of approximately RMB 130 million in 2025, but the actual financial impact relating to the settlement will depend on the results of the review and review by the company's independent auditors.

Zhitong Finance App News, China Tongpo (01763.HK) issued an announcement. On December 31, 2025, according to the relevant authorities, the company's non-wholly-owned subsidiary, Shenzhen CNNC Headway Biotechnology Co., Ltd. (Headway), should recently make up corporate income tax, value-added tax and other taxes of RMB 188 million from January 1, 2021 to December 31, 2024, and a total of RMB 271 million in late fees, mainly involving sales expenses and abnormal inventory losses of RMB 271 million during the aforementioned year. As of the date of this announcement, Headway has paid this tax. The tax-related matter is expected to affect the annual profit due to equity shareholders of approximately RMB 130 million in 2025, but the actual financial impact relating to the settlement will depend on the results of the review and review by the company's independent auditors.